Sorry, I don't know specifically what the DSMB was asked to
Sorry, I don't know specifically what the DSMB was asked to do on Monday, and don't have anything to add to what everyone else here has already said. For sure they were asked to review adverse events, and if the addition of leronlimab to standard of care was harmful, they would have stopped the study.
I am guessing they reviewed the number of deaths and other SAEs in each arm, and the difference wasn't large enough (according to what criteria?) to recommend doing anything besides continuing the study. I thought it possible they could have seen far fewer deaths in the leronlimab arm and stopped the study, but that didn't happen. It's possible they weren't asked to make that recommendation one way or the other at this point. The great majority of DSMB meetings concludes with "continue the study as planned." That's what we got. Now we wait for interim data analysis in ~8 weeks, which will have statistical guidelines for stopping for efficacy and futility, and for continuing on to full enrollment of 390.
If mild to moderate data show significant clinical benefit, these safety data in severe to critical Covid will help support approval (at least for mild to moderate Covid). Hopefully we get that good data, and FDA will want to see everything we have for LL in Covid (all EIND, CD10, and CD12 data up to that point) to decide on EUA. We should find out next week some time.
1
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
LG's Triumph with PRISM AI Nobody said corporate recognition was easy, but when you nab three awards in one go, you're making waves in the right pool. That's precisely what LG Electronics did with their PRISM AI platform at the 2026 AMEC Global Communication Effectiveness Awards. This ain't your ordinary pat on the back; it's a full orchestra applaud. Gold in the Best Use...
Continue Reading
Spotlight on Ardelyx: The Legal Smoke Signal Ah, lawsuits. They're like bad weather for companies—sometimes, you know they're coming, and they still hit you hard. Ardelyx's investors who've been in the game from January 13, 2025, to August 6, 2026, are now dealing with just such a storm. What's the Lawsuit Racket? Faruqi & Faruqi, LLP, a securities law firm that seems...
Continue Reading
A Remarkable Milestone in Healthcare Leadership It's not every day someone hangs up their boots after 46 years of relentlessly steering the ship, especially in the tumultuous seas of healthcare. Come June 1, 2027, Lee Ann Stember plans to do just that as she retires as President & CEO of the National Council for Prescription Drug Programs (NCPDP). Her tenure is marked by...
Continue Reading
Unearthing the Heartbeat of a Bygone Era Picture this: a bustling fairground teeming with the simple pleasures of bygone days, where the echoes of tradition mingle with the excitement of competition. This is the vivid tapestry that Dr. Paul J. Carr paints in his latest historical exposé, Farming, Community, and the Legacy of The Suffolk County Agricultural Society's...
Continue Reading
Storm's Brewing for Lululemon It ain't all zen at Lululemon these days. Amidst the yoga mats and stretchy pants, shareholders are unrolling lawsuits like it’s the new Pilates fad. A class action's been slapped on Lululemon Athletica Inc. (NASDAQ: LULU) over alleged investor deception, leaving quite a few with bruised portfolios. The Crux of the Lawsuit So, why is the...
Continue Reading
Modaxo Steps Up for UITP Summit Hamburg 2027 Well, Modaxo's back at it again, laying down roots in the public transport sector. Fresh off the press, they've announced they'll be a Platinum Partner for the UITP Summit in Hamburg 2027. That's not just a handshake for the cameras, folks. It's a clear shout-out about where they see themselves in this industry. Living Their...
Continue Reading
Sometimes the anticipation of a financial report presentation feels akin to waiting for a storm to pass or the sun to finally break through after what seems like endless rain. That’s the kind of vibe we're getting from Sectra's upcoming six-month report presentation. Slated for November 25, President Torbjörn Kronander and CFO Jessica Holmquist will be stepping up to...
Continue Reading
Venturing into Hospitality Real Estate If you're in the hospitality game, the question of whether to buy or to lease your property can loom like a shadow or shine like an opportunity. The latest episode of the Owner's Edge Podcast by Bielat Santore & Company dives into this headfirst, armed with over 45 years of brokering experience in hospitality transactions. They don't...
Continue Reading
Bridging the Gap: Parks and Military Communities Fancy title, ain't it? But what truly matters here is how the National Park Foundation (NPF) is setting a new stage for the troops and their families. The spotlight isn't just on faceless numbers; it's on people—those who serve, their loved ones, and the memories they make far from battlefields. Launching this initiative...
Continue Reading
From Humble Beginnings to Industry Authority No one ever started a business thinking it would last two decades without at least a bit of grit and determination. Back in 2006, John Wierzgac decided to leap into the unknown with WZC Networking. It all began with three stalwart customers and a single engineering brain powered by resolve. John's motivation stemmed from...
Continue Reading
Top 5 Most Recently Viewed Articles
Understanding Artificial General Intelligence Artificial general intelligence (AGI) remains a topic of immense discussion and speculation in the tech world. Notable figures, including Andrej Karpathy, who formerly served as Tesla's senior director of AI, have weighed in on the current state of AGI and its potential future. Karpathy believes that the development of AGI is...
Continue Reading
Understanding Exxon Mobil's Short Interest Trends Exxon Mobil's short interest as a percent of public float has experienced a notable increase of 11.22% since its last report. Presently, there are approximately 47.20 million shares sold short, which comprises about 1.09% of all available shares for trading. This increase highlights an essential aspect of the market's view...
Continue Reading
Lesaffre Enhances Its RD&I with Altar Acquisition MARCQ-EN-BARŒUL, France - Lesaffre, a leading global player in fermentation and microorganisms, has recently announced the acquisition of Altar, a French start-up renowned for its expertise in Adaptive Laboratory Evolution (ALE). This acquisition will significantly augment Lesaffre's ability to innovate within the realms...
Continue Reading
PagerDuty, Inc. (NYSE:PD) made waves back in early 2023 by bringing in Pritesh Parekh as Chief Information Security Officer and Rukmini Reddy as Senior VP of Engineering. Desks were buzzing about these moves, with folks wondering if this was the game-changer PagerDuty needed to stay ahead in a crowded market. Security Reboot: Pritesh Parekh’s Appointment Parekh rolled...
Continue Reading
New Era for Beyond Meat's Stockholders Beyond Meat, Inc. (NASDAQ: BYND), a frontrunner in the plant-based meat industry, recently made a significant announcement that will influence its stockholders and potential investors. The company stated that the lock-up restrictions on the recently exchanged shares will lift, allowing registered stakeholders greater freedom in...
Continue Reading